Fibronostics is excited to announce our participation in the MASH-TAG 2026 Conference, held from January 8-10, 2026, in beautiful Deer Valley/Park City, UT. This marks our first conference representation of the new year, and we are eagerly looking forward to engaging with the MASH community.

We are especially proud to share that our team has been accepted for a poster presentation titled: “Dynamics of Noninvasive tests (NITs, LIVERFASt (LFAST), FIB-4 and Vibration-controlled transient elastography (VCTE, Fibroscan), during monitoring therapy with TNR-beta agonist Resmetirom (RT) in patients with MASH- Update.”

This presentation will delve into the dynamics of noninvasive tests on Resmetirom in MASH patients, offering valuable insights into real-world monitoring and clinical decision-making.

If you are attending MASH-TAG 2026, we warmly invite you to connect with us! Please find us during the poster session to discuss these crucial dynamics and their implications for liver health. We are keen to share our findings and engage in thoughtful discussions with fellow researchers and clinicians.

We anticipate a productive and insightful conference experience at MASH-TAG 2026!